Inflammatory pain disrupts the orbitofrontal neuronal activity and risk-assessment performance in a rodent decision-making task.

Pain

Departamento de Biologia Experimental, Faculdade de Medicina, Universidade do Porto, Porto, Portugal IBMC - Instituto de Biologia Molecular e Celular, Universidade do Porto, Porto, Portugal Centro de Matemática da Universidade do Porto, Porto, Portugal.

Published: August 2012

It has been recently described that disruption of the neural mechanisms of emotion-based decision making occurs in both chronic pain patients and in animal models of pain; moreover, it also has been shown that chronic pain causes morphological and functional changes in the prefrontal cortex that may be crucial for this decision-making dysfunction. However, it is not known whether pain alone is capable of altering the neuronal encoding of decision exhibited by prefrontal neurons. We have previously shown that naïve animals have risk-averse performance in the rodent gambling task, whereas chronic pain animals reverse their choice preference and become risk prone. Using this paradigm, we chronically implanted arrays of multielectrodes and recorded from neuronal ensembles in the orbitofrontal cortex of freely moving animals performing 4 sessions of the rodent gambling task: 2 in control conditions and 2 after the onset of inflammatory pain induced by complete Freund's adjuvant injection. Our results show that the instantaneous neuronal firing rate was correlated with the probability of choosing a specific lever in 62.5% of the neurons; however, although in the control sessions 61% of the neurons encoded the reward magnitude, after the pain onset only 16% of the neurons differentiated small from large rewards. Moreover, we found that the fraction of risk-sensitive neurons recorded in each session predicted the overall risk bias of the animal. Our data suggest that orbitofrontal cortex encoding of risk preference is compromised in chronic pain animals.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.pain.2012.04.011DOI Listing

Publication Analysis

Top Keywords

chronic pain
16
inflammatory pain
8
performance rodent
8
pain
8
rodent gambling
8
gambling task
8
pain animals
8
orbitofrontal cortex
8
neurons
5
pain disrupts
4

Similar Publications

Objectives: Extracorporeal shock wave lithotripsy (ESWL) with endotherapy (ET) is the first-line treatment in patients with chronic pancreatitis (CP) and main pancreatic duct stone (PDS). Our study aimed to evaluate factors that predict the outcome of ESWL in CP patients with PDS.

Methods: We retrospectively analyzed data of 166 patients with CP and radiopaque PDS.

View Article and Find Full Text PDF

Background: Between half and three quarters of the working-age population in today's industrialized globe suffers from lower back pain. The presence of a myofascial trigger point-a hyperirritable painful area comprised of a small number of muscle fibers-identifies mechanical back pain sufferers as suffering from myofascial pain syndrome, a chronic pain disorder. This research objectives to determine whether mechanical back pain patients' pain severity and functional disabilities are influenced by electromagnetic field therapy.

View Article and Find Full Text PDF

Background: Chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS) is a prevalent condition in urology characterized by chronic pain. The pathogenesis of CP/CPPS remains unclear.

Methods: We enrolled 45 eligible CP/CPPS patients and 45 healthy volunteers.

View Article and Find Full Text PDF

Persistent sciatic artery (PSA) is a rare anatomic variant disease with an incidence of approximately 0.025%-0.05% it is considered to be an axial congenital vascular malformation, which may be related to the failure of sciatic artery degeneration and iliofemoral artery dysplasia.

View Article and Find Full Text PDF

Background: Early treatment initiation is one of the strongest predictors of good treatment response in axial spondyloarthritis (axSpA). Recently, the Assessment in SpondyloArthritis International Society (ASAS) defined early axSpA as a diagnosis of axSpA with a duration of axial symptoms equal to or less than 2 years. Tofacitinib is a Janus kinase (JAK) inhibitor for the treatment of ankylosing spondylitis.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!